First Quadrant’s Veracyte VCYT Stock Holding History

First Quadrant’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,440	Closed	-$264K	–	687
2019 Q4	$264K	Sell	9,440 -4,082	-30%	-$106K	0.02%	376
2019 Q3	$325K	Sell	13,522 -2,150	-14%	-$57.2K	0.03%	360
2019 Q2	$447K	Buy	15,672 +10,255	+189%	+$256K	0.03%	419
2019 Q1	$136K	Sell	5,417 -7,470	-58%	-$143K	0.01%	547
2018 Q4	$162K	Buy	+12,887	New	+$152K	0.01%	574

Other funds holding VCYT

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Quadrant's VCYT Position: Q1 2020 in Review

First Quadrant sold out of Veracyte (VCYT) in Q1 2020, closing a stake of 9,440 shares — an estimated $264K sold.

First Quadrant first reported a position in VCYT in Q4 2018 and held it in 5 quarters. The position peaked at $447K in Q2 2019. 165 funds tracked by Wall St. Rank hold VCYT as of Q1 2020.

First Quadrant reported no remaining Veracyte position as of Q1 2020 after selling out during the quarter.
First Quadrant sold 9,440 Veracyte shares in Q1 2020, an estimated $264K.
First Quadrant first reported a position in Veracyte in Q4 2018 and held it in 5 quarters.
First Quadrant's Veracyte position peaked at $447K in Q2 2019.
165 funds tracked by Wall St. Rank held Veracyte as of Q1 2020.

Based on First Quadrant's 13F filing for Q1 2020, filed 5 May 2020.